Peng Luo
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 6
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 3
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Chunmeng Shi (24 shared papers)Ziwen Wang (3 shared papers)Hongming Miao (3 shared papers)Min Luo (2 shared papers)Qingzhi Jiang (4 shared papers)Juanjuan Ou (2 shared papers)Yang Wang (6 shared papers)Yawei Wang (4 shared papers)
- Journals
- OncoTargets and Therapy (2 papers)Cancer Letters (2 papers)DNA and Cell Biology (2 papers)Biochemical and Biophysical Research Communications (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Peng Luo
40 papers receiving 513 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 100
- Aging 11
- Molecular Biology 278
- Immunology 83
- Rehabilitation 26
Countries citing papers authored by Peng Luo
This map shows the geographic impact of Peng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Luo more than expected).
Fields of papers citing papers by Peng Luo
This network shows the impact of papers produced by Peng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Luo. The network helps show where Peng Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2020 | 62 | |
| 3 | 2023 | 52 | |
| 4 | 2016 | 50 | |
| 5 | Artesunate induces ER-derived-ROS-mediated cell death by disrupting labile iron pool and iron redistribution in hepatocellular carcinoma cells. | 2021 | 33 |
| 6 | 2020 | 28 | |
| 7 | 2019 | 25 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 16 | |
| 10 | 2020 | 16 | |
| 11 | 2020 | 15 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 11 | |
| 15 | 2018 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2024 | 8 | |
| 18 | 2025 | 8 | |
| 19 | 2021 | 7 | |
| 20 | The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathway. | 2019 | 6 |
About Peng Luo
Peng Luo is a scholar working on Molecular Biology, Cancer Research, Immunology, Cell Biology and Genetics, having authored 41 papers that have together received 518 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), RNA Interference and Gene Delivery (4 papers), Sperm and Testicular Function (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), RNA modifications and cancer (3 papers), Autophagy in Disease and Therapy (3 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (100 citations), Aging (11 citations), Molecular Biology (278 citations), Immunology (83 citations) and Rehabilitation (26 citations). Peng Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chunmeng Shi, Ziwen Wang, Hongming Miao, Min Luo, Qingzhi Jiang, Juanjuan Ou, Yang Wang, Yawei Wang, Zelin Chen and Huilan Wang. Their work appears in journals such as OncoTargets and Therapy, Cancer Letters, DNA and Cell Biology, Biochemical and Biophysical Research Communications and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.